Castleark Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | – | Sell |
-423,260
| Closed | -$22.8M | – | 380 |
|
|
2016
Q3 | $22.8M | Sell |
423,260
-229,310
| -35% | -$12.4M | 0.69% | 38 |
|
|
2016
Q2 | $48M | Buy |
652,570
+76,990
| +13% | +$5.66M | 1.53% | 9 |
|
|
2016
Q1 | $36.8M | Sell |
575,580
-172,820
| -23% | -$11M | 1.15% | 26 |
|
|
2015
Q4 | $51.5M | Buy |
748,400
+355,090
| +90% | +$24.4M | 1.55% | 10 |
|
|
2015
Q3 | $23.3M | Buy |
+393,310
| New | +$23.3M | 0.75% | 35 |
|
|
2015
Q2 | – | Sell |
-27,700
| Closed | -$1.79M | – | 375 |
|
|
2015
Q1 | $1.79M | Buy |
27,700
+15,100
| +120% | +$974K | 0.04% | 271 |
|
|
2014
Q4 | $744K | Buy |
+12,600
| New | +$744K | 0.02% | 277 |
|
|
2013
Q4 | – | Sell |
-12,100
| Closed | -$619K | – | 322 |
|
|
2013
Q3 | $619K | Buy |
+12,100
| New | +$619K | 0.02% | 272 |
|